Tango Therapeutics Stock Buy Hold or Sell Recommendation
| TNGX Stock | USD 3.10 0.16 5.44% |
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Tango Therapeutics is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Tango Therapeutics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Tango Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Tango Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide. In addition, we conduct extensive research on individual companies such as Tango and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Tango Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Tango |
Execute Tango Therapeutics Buy or Sell Advice
The Tango recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Tango Therapeutics. Macroaxis does not own or have any residual interests in Tango Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Tango Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Tango Therapeutics Trading Alerts and Improvement Suggestions
| Tango Therapeutics generated a negative expected return over the last 90 days | |
| Tango Therapeutics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 36.53 M. Net Loss for the year was (101.74 M) with loss before overhead, payroll, taxes, and interest of (81.05 M). | |
| Tango Therapeutics currently holds about 416.36 M in cash with (117.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.73, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 87.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Tango Therapeutics, Inc. Receives Consensus Recommendation of Buy from Analysts - MarketBeat |
Tango Therapeutics Returns Distribution Density
The distribution of Tango Therapeutics' historical returns is an attempt to chart the uncertainty of Tango Therapeutics' future price movements. The chart of the probability distribution of Tango Therapeutics daily returns describes the distribution of returns around its average expected value. We use Tango Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Tango Therapeutics returns is essential to provide solid investment advice for Tango Therapeutics.
| Mean Return | -1.24 | Value At Risk | -8.06 | Potential Upside | 7.37 | Standard Deviation | 6.78 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Tango Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Tango Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Tango Therapeutics, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Tango Therapeutics back and forth among themselves.
| Shares | Balyasny Asset Management Llc | 2024-09-30 | 2.7 M | State Street Corp | 2024-09-30 | 2.3 M | Adage Capital Partners Gp Llc | 2024-09-30 | 2.3 M | Deerfield Management Co | 2024-09-30 | 1.5 M | Geode Capital Management, Llc | 2024-09-30 | 1.4 M | Casdin Capital, Llc | 2024-09-30 | 1.2 M | Baker Bros Advisors Lp | 2024-09-30 | 750 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-09-30 | 708.4 K | Bessemer Group Inc | 2024-09-30 | 708.4 K | Trv Gp Iv, Llc | 2024-09-30 | 16.9 M | Ecor1 Capital, Llc | 2024-09-30 | 13.3 M |
Tango Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Tango Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Tango Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Tango stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.2 | |
β | Beta against Dow Jones | -2.09 | |
σ | Overall volatility | 6.84 | |
Ir | Information ratio | -0.19 |
Tango Therapeutics Volatility Alert
Tango Therapeutics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Tango Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Tango Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Tango Therapeutics Fundamentals Vs Peers
Comparing Tango Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Tango Therapeutics' direct or indirect competition across all of the common fundamentals between Tango Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Tango Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Tango Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Tango Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Tango Therapeutics to competition |
| Fundamentals | Tango Therapeutics | Peer Average |
| Return On Equity | -0.49 | -0.31 |
| Return On Asset | -0.22 | -0.14 |
| Profit Margin | (2.84) % | (1.27) % |
| Operating Margin | (2.83) % | (5.51) % |
| Current Valuation | 77.34 M | 16.62 B |
| Shares Outstanding | 107.42 M | 571.82 M |
| Shares Owned By Insiders | 12.84 % | 10.09 % |
| Shares Owned By Institutions | 87.16 % | 39.21 % |
| Number Of Shares Shorted | 7.22 M | 4.71 M |
| Price To Book | 1.45 X | 9.51 X |
| Price To Sales | 7.68 X | 11.42 X |
| Revenue | 36.53 M | 9.43 B |
| Gross Profit | (81.05 M) | 27.38 B |
| EBITDA | (111.76 M) | 3.9 B |
| Net Income | (101.74 M) | 570.98 M |
| Cash And Equivalents | 416.36 M | 2.7 B |
| Cash Per Share | 4.73 X | 5.01 X |
| Total Debt | 38.92 M | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 9.76 X | 2.16 X |
| Book Value Per Share | 2.13 X | 1.93 K |
| Cash Flow From Operations | (117.98 M) | 971.22 M |
| Short Ratio | 2.31 X | 4.00 X |
| Earnings Per Share | (1.15) X | 3.12 X |
| Target Price | 11.5 | |
| Number Of Employees | 140 | 18.84 K |
| Beta | 0.88 | -0.15 |
| Market Capitalization | 333 M | 19.03 B |
| Total Asset | 402.57 M | 29.47 B |
| Retained Earnings | (371.26 M) | 9.33 B |
| Working Capital | 300.6 M | 1.48 B |
| Net Asset | 402.57 M |
Note: Acquisition by Rothenberg Mace of 10000 shares of Tango Therapeutics at 3.78 subject to Rule 16b-3 [view details]
Tango Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Tango . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Tango Therapeutics Buy or Sell Advice
When is the right time to buy or sell Tango Therapeutics? Buying financial instruments such as Tango Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Tango Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency Thematic Idea Now
Cryptocurrency
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Tango Stock Analysis
When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.